These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1708077)
1. Co-expression of cholecystokinin mRNA and tyrosine hydroxylase mRNA in populations of rat substantia nigra cells; a study using a combined radioactive and non-radioactive in situ hybridization procedure. Kiyama H; McGowan EM; Emson PC Brain Res Mol Brain Res; 1991 Jan; 9(1-2):87-93. PubMed ID: 1708077 [TBL] [Abstract][Full Text] [Related]
2. Repeated administration of MDMA down-regulates preprocholecystokinin mRNA expression but not tyrosine hydroxylase mRNA expression in neurones of the rat substantia nigra. Wotherspoon G; Savery D; Priestley JV; Rattray M Brain Res Mol Brain Res; 1994 Aug; 25(1-2):34-40. PubMed ID: 7984049 [TBL] [Abstract][Full Text] [Related]
3. Decreased tyrosine hydroxylase mRNA but not cholecystokinin mRNA in the pars compacta of the substantia nigra and ventral tegmental area of aged rats. Schuligoi R; Fernandez J; Heavens RP; Sirinathsinghji DJ Brain Res Mol Brain Res; 1993 Sep; 19(4):333-8. PubMed ID: 7901729 [TBL] [Abstract][Full Text] [Related]
4. Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones. Augood SJ; Westmore K; McKenna PJ; Emson PC Brain Res Mol Brain Res; 1993 Dec; 20(4):328-34. PubMed ID: 7906851 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry. Seroogy K; Schalling M; Brené S; Dagerlind A; Chai SY; Hökfelt T; Persson H; Brownstein M; Huan R; Dixon J Exp Brain Res; 1989; 74(1):149-62. PubMed ID: 2564343 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration. Cottingham SL; Pickar D; Shimotake TK; Montpied P; Paul SM; Crawley JN Cell Mol Neurobiol; 1990 Mar; 10(1):41-50. PubMed ID: 1970757 [TBL] [Abstract][Full Text] [Related]
7. The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined by in situ hybridization. Savasta M; Ruberte E; Palacios JM; Mengod G Neuroscience; 1989; 29(2):363-9. PubMed ID: 2566954 [TBL] [Abstract][Full Text] [Related]
8. Combination of alkaline phosphatase in situ hybridization with immunohistochemistry: colocalization of calretinin-mRNA with calbindin and tyrosine hydroxylase immunoreactivity in rat substantia nigra neurons. Heppelmann B; Señaris R; Emson PC Brain Res; 1994 Jan; 635(1-2):293-9. PubMed ID: 7909717 [TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain. Zhang Y; Angulo JA Synapse; 1996 Nov; 24(3):218-23. PubMed ID: 8923661 [TBL] [Abstract][Full Text] [Related]
10. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons. Weiss-Wunder LT; Chesselet MF Neuroscience; 1992 Jul; 49(2):297-305. PubMed ID: 1359452 [TBL] [Abstract][Full Text] [Related]
11. Cellular localization of tyrosine hydroxylase mRNA and cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sirinathsinghji DJ; Kupsch A; Mayer E; Zivin M; Pufal D; Oertel WH Brain Res Mol Brain Res; 1992 Jan; 12(1-3):267-74. PubMed ID: 1347634 [TBL] [Abstract][Full Text] [Related]
12. Haloperidol activates tyrosine hydroxylase gene-expression in the rat substantia nigra, pars reticulata. Stork O; Hashimoto T; Obata K Brain Res; 1994 Jan; 633(1-2):213-22. PubMed ID: 7907932 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine hydroxylase mRNA in the dopaminergic neurons of young adult and aged mice by in situ hybridization. Gupta M; Stoler MH; Fossom LH; Tank AW Neurosci Lett; 1990 Oct; 119(1):49-52. PubMed ID: 1982959 [TBL] [Abstract][Full Text] [Related]
14. Lesions of nigrostriatal pathway reduce expression of tyrosine hydroxylase gene in residual dopaminergic neurons of substantia nigra. Shirao T; Evinger MJ; Iacovitti L; Reis DJ Neurosci Lett; 1992 Jul; 141(2):208-12. PubMed ID: 1359468 [TBL] [Abstract][Full Text] [Related]
16. Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. Ingram SM; Krause RG; Baldino F; Skeen LC; Lewis ME J Comp Neurol; 1989 Sep; 287(2):260-72. PubMed ID: 2794128 [TBL] [Abstract][Full Text] [Related]
17. Does cholecystokinin colocalize with dopamine in the human substantia nigra? Palacios JM; Savasta M; Mengod G Brain Res; 1989 May; 488(1-2):369-75. PubMed ID: 2743135 [TBL] [Abstract][Full Text] [Related]
18. Combined in situ hybridization and immunocytochemistry in the assay of pharmacological effects on tyrosine hydroxylase mRNA concentration. Pasinetti GM; Morgan DG; Johnson SA; Lerner SP; Myers MA; Poirier J; Finch CE Pharmacol Res; 1989; 21(3):299-311. PubMed ID: 2568627 [TBL] [Abstract][Full Text] [Related]
19. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Javoy-Agid F; Hirsch EC; Dumas S; Duyckaerts C; Mallet J; Agid Y Neuroscience; 1990; 38(1):245-53. PubMed ID: 1979431 [TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta. Arbogast LA; Voogt JL Endocrinology; 1991 Feb; 128(2):997-1005. PubMed ID: 1703487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]